Empowered Funds LLC Makes New Investment in Chemed Corporation $CHE

Key Points

• Empowered Funds LLC initiated a position in Chemed during the second quarter, purchasing 2,060 shares valued at approximately $959,000. Institutional investors collectively own 95.85% of the company.
• Chemed reported quarterly EPS of $6.06, exceeding the $5.60 consensus estimate, while revenue rose 8.8% year over year to $673.25 million. The company issued fiscal 2026 EPS guidance of $25.00–$25.75.
• Chemed increased its quarterly dividend from $0.60 to $0.70 per share, implying an annualized dividend of $2.80 and a 0.5% yield. Analysts maintain a consensus “Hold” rating with an average price target of $530.75.

Empowered Funds LLC acquired a new position in Chemed Corporation (NYSE:CHE - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 2,060 shares of the company's stock, valued at approximately $959,000.

Several other hedge funds have also recently bought and sold shares of CHE. Monetary Solutions Ltd bought a new stake in shares of Chemed in the 4th quarter valued at approximately $25,000. Los Angeles Capital Management LLC acquired a new stake in Chemed in the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. acquired a new stake in Chemed in the 4th quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Chemed during the second quarter worth approximately $34,000. Finally, Versant Capital Management Inc boosted its position in Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company's stock worth $35,000 after purchasing an additional 75 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Stock Performance

CHE opened at $520.82 on Friday. The stock has a market cap of $6.81 billion, a price-to-earnings ratio of 26.16, a PEG ratio of 1.99 and a beta of 0.51. The business has a 50 day moving average of $516.70 and a 200-day moving average of $451.82. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. During the same period in the previous year, the company posted $4.27 EPS. The firm's quarterly revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities research analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th were given a dividend of $0.70 per share. The ex-dividend date of this dividend was Monday, August 17th. This is a positive change from Chemed's previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed's payout ratio is currently 14.06%.

Wall Street Analyst Weigh In

Several analysts have issued reports on CHE shares. Bank of America restated a "neutral" rating on shares of Chemed in a research report on Wednesday, July 29th. Royal Bank Of Canada upped their price objective on shares of Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a research note on Thursday, July 30th. Wall Street Zen raised shares of Chemed from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 1st. Oppenheimer boosted their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research note on Friday, July 31st. Finally, Weiss Ratings upgraded shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, July 17th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $530.75.

Insider Buying and Selling at Chemed

In other news, CEO Kevin McNamara sold 2,000 shares of the business's stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total value of $1,079,020.00. Following the transaction, the chief executive officer owned 70,418 shares in the company, valued at $37,991,215.18. The trade was a 2.76% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Andrea Lindell sold 1,347 shares of the company's stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 6,537 shares of company stock worth $3,406,014 in the last quarter. 3.33% of the stock is owned by insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.